| Name | Glucagon receptor antagonists-5 |
|---|
| Description | Glucagon receptor antagonists-5 (compound 13K) is a potent and orally bioavailable indazole-based glucagon receptor antagonist (Ki=32 nM). Glucagon receptor antagonists-5 has potential for the treatment of type 2 diabetes mellitus (T2DM)[1]. |
|---|---|
| Target |
Ki: 32 nM (glucagon receptor)[1] |
| References |
| Molecular Formula | C30H29ClF3N3O3 |
|---|---|
| Molecular Weight | 572.02 |